Spruce Biosciences sprucebiosciences.com


Public lists: Rare Diseases (230)

Spruce Biosciences (NASDAQ: SPRB) is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company's mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the "stress pathway").

Spruce Biosciences (NASDAQ: SPRB) is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company's mission is to develop meaningful therapies for patients with rare diseases affecting the hypothal...Show all

Company (IPO / Went public)

Phone: 414-294-1687

Fax:

2001 Junipero Serra Blvd.
Suite 640
San Francisco, 94104
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Spruce Biosciences $108M Oct 9, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Spruce Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Corticotropin releasing factor receptor antagonists Apr 18, 2019 Dec 01, 2020 Patent
Corticotropin releasing factor receptor antagonists Oct 22, 2020 Application
Corticotropin releasing factor receptor antagonists Feb 11, 2020 Application